肺癌患者免疫檢查點抑制劑肺炎的研究進展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

韓旺 , 趙章雪 ,  邱玉英

南京大學醫學院附屬鼓樓醫院呼吸與危重癥醫學科（江蘇南京 210008）;

Corresponding?author：

邱玉英, Email: qiuyuying@sina.com

Keywords：

DOI：

10.7507/1671-6205.202510083

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 韓旺, 趙章雪, 邱玉英. 肺癌患者免疫檢查點抑制劑肺炎的研究進展. Chinese Journal of Respiratory and Critical Care Medicine, 2026, 25(6): 444-449. doi: 10.7507/1671-6205.202510083 Copy

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.	Theelen W, Chen D, Verma V, et al. Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Respir Med. 2021, 9(5): 467-475.
14.
15.
16.
17.
18.
19.
20.
21.
22.	Li X, Liu Y, Gui J, et al. Cell Identity and Spatial Distribution of PD-1/PD-L1 Blockade Responders. Adv Sci (Weinh). 2024;11(41): e2400702.
23.
24.
25.	Lécuyer R, Issa N, Camou F, et al. Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying Disease: A Retrospective Multicenter Study. Chest. 2024, 165(6): 1319-1329.
26.	Jaramillo Cartagena A, Asowata OE, Ng D, et al. An overview of the laboratory diagnosis of Pneumocystis jirovecii pneumonia. J Clin Microbiol. 2025, 63(3): e0036124.
27.
28.
29.
30.
31.
32.
33.	Zhang Z, Zhang L, Wang K, et al. Single-cell landscape of bronchoalveolar immune cells in patients with immune checkpoint inhibitor-related pneumonitis. NPJ Precis Oncol. 2024, 8(1): 226.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13. Theelen W, Chen D, Verma V, et al. Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Respir Med. 2021, 9(5): 467-475.
14.
15.
16.
17.
18.
19.
20.
21.
22. Li X, Liu Y, Gui J, et al. Cell Identity and Spatial Distribution of PD-1/PD-L1 Blockade Responders. Adv Sci (Weinh). 2024;11(41): e2400702.
23.
24.
25. Lécuyer R, Issa N, Camou F, et al. Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying Disease: A Retrospective Multicenter Study. Chest. 2024, 165(6): 1319-1329.
26. Jaramillo Cartagena A, Asowata OE, Ng D, et al. An overview of the laboratory diagnosis of Pneumocystis jirovecii pneumonia. J Clin Microbiol. 2025, 63(3): e0036124.
27.
28.
29.
30.
31.
32.
33. Zhang Z, Zhang L, Wang K, et al. Single-cell landscape of bronchoalveolar immune cells in patients with immune checkpoint inhibitor-related pneumonitis. NPJ Precis Oncol. 2024, 8(1): 226.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.

Previous Article
代謝組學：開啟支氣管哮喘精準診療的新視角
Next Article
替爾泊肽用于成人阻塞性睡眠呼吸暫停伴肥胖治療的研究進展

Chinese Journal of Respiratory and Critical Care Medicine

肺癌患者免疫檢查點抑制劑肺炎的研究進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content